Table 1.
The pathological characteristics of breast cancer patients
| Variables | N = 30 | % |
|---|---|---|
| Age (years): ≤ 55 | 14 | 46.7 |
| > 55 | 16 | 53.3 |
| Histological type | ||
| Invasive ductal carcinoma (IDC) | 20 | 66.7 |
| Ductal carcinoma in situ (DCIS) | 8 | 26.7 |
| Invasive lobular carcinoma (ILC) | 2 | 6.7 |
| TNM stage | ||
| I | 3 | 10 |
| II | 13 | 43.3 |
| III | 13 | 43.3 |
| IV | 1 | 3.3 |
| Histologic grade | ||
| I | 9 | 30 |
| II | 13 | 43.4 |
| III | 8 | 26.7 |
| Tumor size | ||
| ≥ 2 cm | 12 | 40 |
| < 2 cm | 18 | 60 |
| Lymph node | ||
| Positive | 20 | 66.7 |
| Negative | 10 | 33.3 |
| Estrogen receptor | ||
| Positive | 17 | 56.7 |
| Negative | 13 | 43.3 |
| Progesterone receptor | ||
| Positive | 17 | 56.7 |
| Negative | 13 | 43.3 |
| Her2/neu receptora | ||
| Positive | 10 | 33.3 |
| Negative | 20 | 66.7 |
aHuman epidermal growth factor receptor 2